deferoxamine has been researched along with procaine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Bär, DP; de Smet, M; de With, MC; Kon, M; Kroese, AB; van der Heijden, EP; Werker, PM | 1 |
Deussen, A; Heintz, A; Pexa, A; Rauen, U; Schröder, C | 1 |
de Groot, H; Rauen, U; Wille, T | 1 |
Karck, M; Koch, A; Loganathan, S; Radovits, T; Sack, FU; Szabó, GB | 1 |
Amiot, BP; Chen, HS; Joo, DJ; Li, Y; Nyberg, SL; Rinaldo, P; Shaheen, M | 1 |
6 other study(ies) available for deferoxamine and procaine
Article | Year |
---|---|
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Improving the preservation of isolated rat skeletal muscles stored for 16 hours at 4 degrees C.
Topics: Animals; Antioxidants; Chelating Agents; Chromans; Cryopreservation; Cyclic N-Oxides; Deferoxamine; Diacetyl; Drug Combinations; Electric Stimulation; Energy Metabolism; Glucose; Male; Mannitol; Muscle Contraction; Muscle, Skeletal; Nitrogen Oxides; Oxygen; Potassium Chloride; Procaine; Rats; Rats, Wistar; Time Factors | 2000 |
Preclinical evaluation of coronary vascular function after cardioplegia with HTK and different antioxidant additives.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Biomarkers; Bradykinin; Cardioplegic Solutions; Chromans; Coronary Circulation; Coronary Vessels; Deferoxamine; Glucose; Heart Arrest, Induced; Heart Rate; Male; Mannitol; Myocardial Reperfusion; Organ Preservation; Organ Preservation Solutions; Potassium Chloride; Procaine; Rats; Rats, Wistar; Siderophores; Vasodilation; Vasodilator Agents; Ventricular Dysfunction, Left | 2007 |
Improvement of the cold storage of blood vessels with a vascular preservation solution. Study in porcine aortic segments.
Topics: Adenosine; Alanine; Allopurinol; Animals; Aorta; Aspartic Acid; Buffers; Cell Survival; Citrates; Cold Temperature; Deferoxamine; Endothelial Cells; Glucose; Glutathione; Glycine; Histidine; Hydrogen-Ion Concentration; Insulin; Iron; Iron Chelating Agents; Mannitol; Membrane Potential, Mitochondrial; Mitochondria; Organ Preservation; Organ Preservation Solutions; Platelet Adhesiveness; Potassium Chloride; Procaine; Raffinose; Rewarming; Swine; Time Factors | 2008 |
Deferoxamine, the newly developed iron chelator LK-614 and N-alpha-acetyl-histidine in myocardial protection.
Topics: Animals; Cold Ischemia; Deferoxamine; Glucose; Heart Transplantation; Histidine; Hydroxamic Acids; Iron Chelating Agents; Male; Mannitol; Myocardial Contraction; Myocardial Reperfusion Injury; Organ Preservation; Organ Preservation Solutions; Potassium Chloride; Procaine; Rats; Rats, Inbred Lew; Stroke Volume; Time Factors; Ventricular Function, Left | 2010 |
Cold storage of porcine hepatocyte spheroids for spheroid bioartificial liver.
Topics: Acetylcysteine; Albumins; Ammonia; Animals; Cryopreservation; Deferoxamine; Glucose; Hepatocytes; Iron Chelating Agents; Liver, Artificial; Mannitol; Metabolic Clearance Rate; Organ Preservation Solutions; Oxidation-Reduction; Potassium Chloride; Procaine; Spheroids, Cellular; Swine; Transplantation, Heterologous | 2019 |